Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07199595Not yet recruiting
Randomised trial of dexmedetomidine in supratentorial disease (2 arms), sponsored by Assiut University. Primary endpoints: Intracranial Pressure and Cerebral Perfusion Pressure. Planned start Oct 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07199595.